Colony-stimulating factor-1 receptor inhibition combined with paclitaxel exerts effective antitumor effects in the treatment of ovarian cancer

Co-treatment with PLX3397, a CSF1R inhibitor, and paclitaxel significantly inhibits the growth of #OvarianCancer by altering #MacrophagePhenotypes and reprogramming the #immunosuppressive cell population in the #TumorMicroenvironment. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...